Navigation Links
Type in Biological Technology

Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress

... quarter of 2008. Product revenue from the Onco type DX(R) breast cancer test was $35.2 million in ... increased total cash, in part by expanding Onco type DX access and coverage to a broader breast ... of cancer. Since 2004, we have delivered Onco type DX to more than 100,000 breast cancer patients ...

PacificGMP and USC to Collaborate on Recombinant Protein Development and Manufacturing for Phase 1 Clinical Trial

... fill and finish of purified human recombinant type VII collagen. The recombinant protein will be ... born with defects in the gene that encodes type VII collagen. DEB is characterized by extremely ... for the study. Clinical manufacturing of type VII collagen and related research and development ...

Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients

... study of its oral insulin capsule, ORMD-0801, on type 1 diabetic patients. The completion of this study ... Oramed's first clinical trial on patients with type 1 Diabetes Mellitus, whereas, all Oramed's trials up to date have been conducted on type 2 diabetic patients. This study evaluated safety, ...

Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing

... enables greater than 90 percent purity of any type of cells. Secondly, the Field patents cover the ... to identify and select a particular cell type (e.g. heart cells) and produce a highly purified ... and their ability to differentiate into any cell type for world-class drug development tools. In ...

Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity

... risk of several medical conditions including type 2 diabetes, non-alcoholic fatty liver disease, ... that approximately two-thirds of patients with type 2 diabetes are overweight or obese, with a BMI ... individuals with BMI less than 35 kg/m2 without type 2 diabetes have dyslipidemia and/or hypertension. ...

Researchers enlist DNA to bring carbon nanotubes' promise closer to reality

... single-chirality species of the same electronic type from a synthetic mixture of single-walled ... sequence correctly, it recognizes a particular type of CNT and enables us to sort that variety ... palm and out to your little finger, you form a type of beta sheet. "Such a structure is not known ...

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

... investigational sustained release medication for type 2 diabetes that is injected subcutaneously and ... and in many countries worldwide for people with type 2 diabetes who are unable to achieve good ... development program and in the treatment of type 2 diabetes," said Orville G. Kolterman, M.D., ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... Cancer Survival Rate Among US Males by type - Prostate and Testis (1996-2002) (includes ... the US (2007): Percentage Breakdown by Cancer type - Lung & Bronchus, Prostate, Colon & ... Among African Americans and Whites by Cancer type in the US, 2000- 2004 (includes corresponding ...

It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer

... risk of heart attack and others have linked to type 2 diabetes. deCODE used its population genetics ... laboratory, deCODE offers deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation ... prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer, for the ...

Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer

... that validated multigene assays, such as Onco type DX(R), should be considered as an adjunct to ... obtained from multigene assays, including Onco type DX, leads to a change in treatment decisions in ... from more than 40 countries currently use Onco type DX to predict the likelihood of chemotherapy ...

Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply

... a booster dose of Haemophilus influenzae type b (Hib) vaccine after 12 months of age. The CDC ... About Hib Disease Haemophilus influenzae type b, or Hib, is a bacterium that resides in the ... invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use in ...

Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials

... Phase IIb clinical trial in 494 patients with type 2 diabetes mellitus (T2DM), 'Melogliptin', ... improved glycemic control in patients with type 2 diabetes mellitus and exhibited excellent ... anti-diabetic therapies in patients with type 2 diabetes mellitus". said Mr. Glenn Saldanha, MD ...

Spherix Announces Termination of Arla License Agreement

... as a novel pharmaceutical treatment for type 2 diabetes. Spherix is very satisfied with the ... investigating Naturlose as a treatment for type 2 diabetes in a Phase 3 clinical trial. The ... without any restriction on usages. About type 2 Diabetes ...

Spherix Announces Full-Scale Production of Pharmaceutical Tagatose

... Current Phase 3 Trial of Naturlose(R) for type 2 Diabetes BETHESDA, Md., June 23 ... and safety of Naturlose as a treatment for type 2 diabetes. "Receiving this delivery of ... Naturlose as a novel and natural option to treat type 2 diabetes." Inalco, a global ...

Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions

... delivery of exenatide) for the treatment of type 2 diabetes as a late-breaker at the Annual ... to deliver exenatide therapy for the treatment of type 2 diabetes," said K. Alice Leung, President & ... a 28-day course of ITCA 650 treatment among 44 type 2 diabetes patients (10-12 patients/dose arm) on ...

Diamyd(R) Phase III Study Approved for Younger Patients in the US

... (FDA) to include children with type 1 diabetes from 10 years of age in the company's ... in children and adolescents with recent-onset type 1 diabetes. The European study, which is ... to 20 years, an age group with few recent-onset type 1 diabetes patients. The company is, with the new ...

Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting

... loss and the corresponding positive impact on type 2 diabetes. Data from the phase 3 EQUATE trial ... weight loss with Qnexa stops the progression of type 2 diabetes in obese, non-diabetic patients. The ... with Qnexa can significantly lower blood sugar in type 2 diabetics. "Obesity ...

Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management

... diseases (with a primary focus on type 2 diabetes) from Research to Phase 2 Clinical ... achieved its clinical proof-of-concept for the type 2 diabetes monotherapy indication- and other ... Serono is shareholders of Poxel. About type 2 Diabetes: ...

Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions

... delivery of exenatide for the treatment of type 2 diabetes HAYWARD, Calif., May 27 ... delivery of exenatide) for the treatment of type 2 diabetes as a late-breaker at the Annual ... 44 patients (n= 10-12 patients/dose arm) with type 2 diabetes. (Logo: ...

Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial

... risk of heart attack regardless of heart-attack type (procedural related or spontaneous), size or ... types of heart attacks based on the size and type of heart attack.(3) The types of heart attacks ... to the definition, included: type 1: Spontaneous heart attack caused by a primary ...

A New Era in the Application of Lab-on-a-Chip to Rapid Point-of-Care Diagnosis

... portfolio: a Diagnostic Test Kit for Influenza type A/H1N1 and a MOBILE FIELD UNIT ensuring ... stable under varying ambient conditions. type A/H1N1 detection kits are available across three ... EFADchip , Diagnostic Test Kit for Influenza type A/H1N1 and MOBILE FIELD UNIT visit ....

Lilly Set to Unveil More Than 50 Studies at ASCO 2009

... non-small cell lung cancer (NSCLC), a specific type of NSCLC. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell. ALIMTA is ... non-small cell lung cancer (NSCLC), a specific type of NSCLC, after prior chemotherapy. ALIMTA is not ...

New Danish research shows how oil gets stuck underground

... of the North Sea are primarily chalk the same type of rock that the cliffs of Stevns and Mns in ... is the first time that investigations of this type have been carried out on chalk from an oil field ... of ancient algae. The algae gave their cases a type of "surface coating" to make them resistant to ...

Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes

... investigational sustained release medication for type 2 diabetes that is injected subcutaneously and ... and in many countries worldwide for people with type 2 diabetes who are unable to achieve good ... weekly to significantly advance the treatment of type 2 diabetes," said Daniel M. Bradbury, president ...

Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments

... of Phase 3 clinical development of Syncria in type 2 diabetes. In addition, we made solid financial ... (albiglutide) in the long-term treatment of type 2 diabetes mellitus. Syncria was created by HGS ... Phase 3 development as a potential treatment for type 2 diabetes. For more information about HGS, ...

deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes

... attack, stroke, atrial fibrillation (AF) and type 2 diabetes (T2D). These markers can be ... important genetic risk factor yet found for type 2 diabetes(4). Testing individuals with ... deCODE is offers deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation ...

Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay

... with commercialization plans to make the Onco type DX colon cancer Recurrence Score available to ... assay technology designed for the company's Onco type DX breast cancer assay. More than 1,800 colon ... clinical studies to select the genes for the Onco type DX colon cancer assay. The resulting genes were ...

Spherix Announces 2008 Financial Results

... trial investigating efficacy as a treatment for type 2 diabetes continues on schedule; completion ... efficacy of Naturlose as a novel treatment for type 2 diabetes. I am pleased to report that Spherix ... to study the use of Naturlose as a treatment for type 2 diabetes. Its Spherix Consulting subsidiary ...

Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events

... guidance for evaluating cardiovascular risk in type 2 diabetes agents. Results of this analysis ... morbidity and mortality associated with type 2 diabetes," commented Professor Holman. "This ... to become the first weekly therapy to treat type 2 diabetes with glucose control and weight loss. ...

Surveyed Experts Indicate That Byetta LAR and Victoza Have Advantages Over Actos in the Treatment of Type 2 Diabetes

... Resources' Clinical Gold Standard Status for type 2 Diabetes in 2012, According to a New Report ... most influences their prescribing decisions in type 2 diabetes. Clinical data and the opinions of ... in the market. The new report entitled type 2 Diabetes: Endocrinologists' Satisfaction with ...

MannKind Submits NDA for AFRESA for Treatment of Diabetes

... Inhaler for the treatment of adults with type 1 or type 2 diabetes mellitus for the control of ... 5,300 patients. More than 2,450 subjects with type 1 ...

Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe

... Therapy E valuation F or E arly or N ew Onset type 1 D iabetes), the Phase 3 trial of otelixizumab, ... has begun enrollment of new onset autoimmune type 1 diabetes patients in Europe. In DEFEND, ... development of innovative immune intervention for type 1 diabetes patients. We have begun dosing ...

Assembling cells into artificial 3-D microtissues, including a tiny gland

... of the National Academy of Sciences . One type of cell that needs other cells to make it work ... into all of this, and you need more than one cell type to achieve such regulation." "If you really ... to a lymph node, for example such that one cell type secreted interleukin-3 and thereby kept a second ...

FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen

... in adults and children (4 years and older) with type 1 diabetes or adults with type 2 diabetes. The approval of Apidra(R) ... in adults and children (4 years and older) with type 1 diabetes and adults ...

Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug

... - Isis' first kidney-targeted antisense drug for type 2 diabetes enters clinical development ... of sodium dependent glucose co-transporter type 2 (SGLT2). SGLT2 is the major transporter ... of the antisense drug ISIS-SGLT2Rx to treat type 2 diabetes. Any statement describing Isis' ...

Novel Diabetes Drug Discovery Has Potential to Reverse Disease

... breaking discovery with the potential to reverse type 1 and 2 diabetes. Scientists at CureDM, Inc. ... diagnosis, islet mass is often reduced by 80% in type 1 patients and 50% in type 2 patients, supporting the importance of islet ...

Tips from the journals of the American Society for Microbiology

... infectivity of human rotavirus, adenovirus type 5, poliovirus type 1, and norovirus, as well as feline calicivirus and murine norovirus type 1 from the new ethanol-based sanitizer. ...

University of Minnesota Receives $40 Million for Type 1 Diabetes Research

... translate it into a viable cure for people with type 1 diabetes. The gift is the second ... of the Schulze Diabetes Institute. "Curing type 1 diabetes is possible. We only need to declare ... a sense of urgency and responsibility." type 1 diabetes is a crippling and relentless disease. ...

deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service

... with increased fasting glucose levels and risk of type 2 diabetes (T2D). deCODE will employ its ... them at more than 15 percent greater risk of type 2 diabetes than individuals who carry no copies. ... that underpin glucose regulation and risk of type 2 diabetes. This variant does not confer ...

Tips from the journals of the American Society for Microbiology

... infectivity of human rotavirus, adenovirus type 5, poliovirus type 1, and norovirus, as well as feline calicivirus and murine norovirus type 1 from the new ethanol-based sanitizer. ...
Other Contents
(Date:4/20/2014)... long known that people with Down syndrome have a ... childhood, they haven,t been able to explain why. ... uncovered a connection between the two conditions. , In ... Nature Genetics , the researchers track the genetic chain ... syndrome to the cellular havoc that occurs in ALL. ...
(Date:4/18/2014)... For the past 20 years, researchers have published soil ... findings have suggested that soil organic carbon can be ... systems to no-till systems. However, there is a growing ... corn and soybean rotations without cover crops, small grains, ... stocks at the published rates. , "Some studies have ...
(Date:4/17/2014)... 17 In the most densely forested and most ... two centuries of human needs, values and practices. Disturbances ... forests for agriculture and development, have set the stage ... Forest Service study reports. , The report Five ... management needs in the Northern United States ...
Breaking Biology News(10 mins):Dana-Farber researchers uncover link between Down syndrome and leukemia 2Dana-Farber researchers uncover link between Down syndrome and leukemia 3Researchers question published no-till soil organic carbon sequestration rates 2Researchers question published no-till soil organic carbon sequestration rates 3Researchers question published no-till soil organic carbon sequestration rates 4Five anthropogenic factors that will radically alter northern forests in 50 years 2Five anthropogenic factors that will radically alter northern forests in 50 years 3
(Date:4/17/2014)... a study published today in PLOS Pathogens , ... malaria is common can mount an immune response to ... avoid repeated bouts of high fever and illness and ... bloodstream. The findings may help researchers develop future interventions ... malaria parasite. , Each year, approximately 200 million cases ...
(Date:4/17/2014)... published in the April issue of Immunity , ... for Medical Research, says it,s time to take a ... treating sepsis, which kills millions worldwide every year, ... molecules released into the bloodstream to fight an injury ... necessary for maintaining good health without inflammation, wounds ...
(Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
(Date:4/17/2014)... Irvine, Calif., April 17, 2014 By discovering a ... immediately after a stroke, researchers at UC Irvine and ... therapies that may limit or prevent stroke-induced brain damage. ... the fourth-leading cause of death and primary reason for ... damaged in a stroke and lets blood-borne material into ...
(Date:4/17/2014)... potential to ward off depression among retirees, particularly among ... in The Journals of Gerontology, Series B: ... article " Internet Use and Depression Among Retired Older ... the authors report that Internet use reduced the probability ... study sample. , Late-life depression affects between 5 ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Internet use may cut retirees' depression 2
Other TagsOther Tags